2023
Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part II diagnosis and management
Wei B, Fox L, Kaffenberger B, Korman A, Micheletti R, Mostaghimi A, Noe M, Rosenbach M, Shinkai K, Kwah J, Phillips E, Bolognia J, Damsky W, Nelson C. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part II diagnosis and management. Journal Of The American Academy Of Dermatology 2023, 90: 911-926. PMID: 37516356, DOI: 10.1016/j.jaad.2023.02.073.Peer-Reviewed Original ResearchSevere cutaneous adverse reactionsCutaneous adverse reactionsSystemic symptomsDrug reactionsAdverse reactionsDifferential diagnosisDrug-induced hypersensitivity syndrome/drug reactionDrug-induced hypersensitivity syndromeDiHS/DRESSVisceral organ involvementSteroid-sparing agentCornerstone of managementFirst-line therapyEvidence-based overviewSystemic corticosteroidsHypersensitivity syndromeImmediate discontinuationOrgan involvementRisk stratificationAutoimmune diseasesAdjunctive testNeoplastic disordersDiagnostic criteriaLongitudinal evaluationDiagnosisAssessing the Discriminatory Ability of Diagnostic Criteria for Ulcerative Pyoderma Gangrenosum and Its Mimickers
Ji-Xu A, Liakos W, Merleev A, Brüggen M, Nelson C. Assessing the Discriminatory Ability of Diagnostic Criteria for Ulcerative Pyoderma Gangrenosum and Its Mimickers. JAMA Dermatology 2023, 159: 337-338. PMID: 36652229, PMCID: PMC9857708, DOI: 10.1001/jamadermatol.2022.5978.Peer-Reviewed Original Research
2020
A Multicenter Cross-Sectional Study and Systematic Review of Necrobiotic Xanthogranuloma With Proposed Diagnostic Criteria
Nelson CA, Zhong CS, Hashemi DA, Ashchyan HJ, Brown-Joel Z, Noe MH, Imadojemu S, Micheletti RG, Vleugels RA, Wanat KA, Rosenbach M, Mostaghimi A. A Multicenter Cross-Sectional Study and Systematic Review of Necrobiotic Xanthogranuloma With Proposed Diagnostic Criteria. JAMA Dermatology 2020, 156: 270-279. PMID: 31940000, PMCID: PMC6990734, DOI: 10.1001/jamadermatol.2019.4221.Peer-Reviewed Original ResearchConceptsMulticenter cross-sectional studyNecrobiotic xanthogranulomaCross-sectional studyPlasma cell dyscrasiaDiagnostic criteriaMulticenter cohortMalignant conditionsConsensus exerciseSystematic reviewPeriorbital distributionLymphoproliferative disordersCutaneous lesionsMultiple myelomaMinor criteriaBetter treatment response rateDiagnosis of NXGTertiary academic referral centerNon-Langerhans cell histiocytosisAcademic referral centerTreatment response ratesPennsylvania Health SystemMassachusetts General HospitalBoard-certified dermatologistsIntralesional triamcinoloneIntravenous immunoglobulin